Patenting antibodies: a personal take on maturing technology
14 Jul 2025
As the tools for generating and characterising antibodies become more sophisticated and widely available, patent offices are re-evaluating how they assess key legal requirements...
READ MORE
The main obstacles to obtain patent protection for CAR-T cell-related technologies in Brazil
As research and development efforts move forward in relation to Chimeric antigen receptor CAR-T cells, it is interesting to understand the main patentability issues of...
READ MORE
Patent protection for CRISPR/cas-9 technologies in Brazil
Genome editing using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated 9 (Cas-9) technology holds great potential to accelerate life science research, improve biotechnology, and...
READ MORE
Insights for patent protection of CAR-T cells-related technologies in Brazil
Chimeric antigen receptor (CAR) T-cell therapy is a personalised cancer treatment that is gaining greater visibility and enthusiasm as research advances and success in...
READ MORE
Patenting of stem cells
Posted by Serge Shahinian
01 Aug 2023
What are stem cells and why are they so important? The body is an amazing thing, made up of billions of cells of many different,...
READ MORE
Maximising Patent Term Extension in Korea: strategies and recommendations
Posted by Min Son
24 Jul 2023
Patent Term Extension (PTE) in Korea provides an opportunity to extend the term of a patent based on regulatory approval or Marketing Authorisation (MA)...
READ MORE
Australia’s Full Federal Court diagnoses an outcome, not a product
Posted by Andrew Scott
05 May 2022
Examining a recent court decision; the latest in a long running, multi-jurisdictional dispute between the parties concerning the validity and infringement of claims to...
READ MORE